Do you need a publication with your primary mentor to be competitive on a K application?

By Bouvier Grant Group

We stay current on NIH happenings and would be delighted to keep you informed.

I’m often asked whether applicants to the NIH Career Development Award (K Series) need to have publications with their primary mentor in order to be competitive. The resounding answer is “yes”! Even though this is not written anywhere in NIH’s official guidance, it is a consistent reality in the field.

I know that it sounds counterintuitive: You’re applying for funding to develop expertise in an area, and yet you need already to have demonstrated some expertise in that area. But publishing with your primary mentor provides proof of that initial expertise. It also demonstrates that there is an established relationship with this mentor.

If you do not yet have a first-author publication with your primary mentor, you could:

  1. wait until you have the first-author publication with your primary mentor;
  2. if you have a draft manuscript in review, submit the K application and hope that you could update publication information by the post-submission material deadline of 30 days before the study section meets; or
  3. consider putting in the application and aim to have the publication in press by the time of a resubmission, knowing that few applicants get funded on the first try anyway. This last option might make sense if you don’t have time, for example, if you are concerned about preserving your ESI funding advantage on a future R01 and don’t want to spend many years preparing for, applying for, and conducting a K. Putting in a K submission without the first-author publication would allow you to gather valuable information about what reviewers want to see on your K resubmission. In general, I’m not a fan of researchers submitting an application that they know is unlikely to be funded. But occasionally, it makes sense in terms of the longer-term grantsmanship strategy.

In roughly two decades of reviewing hundreds of K summary statements, I cannot think of a single instance where an applicant was funded without a first-author publication with their primary mentor in the field in which they were applying. And I can think of many cases where reviewers explicitly said, “Come back when you have that publication.”

Dr. Meg Bouvier

Author:
Dr. Meg Bouvier

Margaret Bouvier received her PhD in 1995 in Biomedical Sciences from the Mount Sinai School of Medicine. After an NINDS post-doctoral fellowship, she worked as a staff writer for long-standing NIH Director Dr. Francis Collins in the Office of Press, Policy, and Communications for the Human Genome Project and NHGRI. Since 2007, Meg has specialized in editing and advising on NIH submissions, and began offering virtual courses in 2015.

She’s recently worked with more than 25% of the nation’s highest-performing hospitals*, three of the top 10 cancer hospitals*, three of the top 16 medical schools for research*, and 8 NCI-Designated Cancer Centers.

Her experience at NIH as both a bench scientist and staff writer greatly informs her approach to NIH grantwriting. She has helped clients land over half a billion in federal funding. Bouvier Grant Group is a woman-owned small business.

*As recognized by the 2024/25 US News & World Report honor roll.

Categories:
Bouvier Grant Group logo white
Scroll to Top
We read all NIH notices for our clients. When you join our mailing list, we’ll pass along important changes directly to your inbox, as well as opportunities to improve your grantsmanship skills.
Primary Position
Lead Source

Wait!

Subscribe to our monthly newsletter for the latest NIH news, grantwriting tips, and more.

Newsletter Popup